Weighted event rates | ||||
---|---|---|---|---|
Analgesic (number of trials) | Analgesic | Placebo | RBI (95% CI) | NNT (95% CI) |
Outcome: pain relief | ||||
Naproxen (13) | 59% | 17% | 217% (172 to 265) | 3 (2 to 4) |
Ibuprofen (9) | 70% | 31% | 141% (58 to 268) | 3 (2 to 4) |
Mefenamic acid (3) | 64% | 31% | 103% (65 to 148) | 3 (2 to 5) |
Aspirin (5) | 29% | 18% | 60% (12 to 129) | 10 (6 to 50) |
Weighted event rates | ||||
---|---|---|---|---|
Analgesic (number of trials) | Analgesic | Placebo | RRR (95% CI) | NNT (95% CI) |
Outcome: use of rescue analgesics | ||||
Naproxen (10) | 18% | 51% | 62% (56 to 68) | 4 (3 to 5) |
Ibuprofen (2) | 13% | 57% | 77% (59 to 87) | 3 (2 to 4) |
Aspirin (3) | 39% | 70% | 21% (−8 to 42) | Not significant |
Weighted event rates | ||||
---|---|---|---|---|
Analgesic (number of trials) | Analgesic | Placebo | RRR (95% CI) | NNT (95% CI) |
* Abbreviations defined in glossary. Data provided by author. | ||||
Outcome: restrictions in daily life | ||||
Naproxen (7) | 60% | 86% | 29% (15 to 40) | 5 (3 to 8) |
Ibuprofen (3) | 12% | 55% | 74% (58 to 84) | 3 (2 to 5) |
Aspirin (3) | 50% | 62% | 18% (−4 to 36) | Not significant |